Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
Pilot phase I/II personalized therapy trial for metastatic colorectal cancer: evaluating the feasibility of protein pathway activation mapping for stratifying patients to therapy with imatinib and panitumumab. [electronic resource] by
- Pierobon, M
- Silvestri, A
- Spira, A
- Reeder, A
- Pin, E
- Banks, S
- Parasido, Erika
- Edmiston, K
- Liotta, L
- Petricoin, E
Producer: 20150122
In:
Journal of proteome research vol. 13
Availability: No items available.
|
|
5.
|
HSP-90 inhibitor ganetespib is synergistic with doxorubicin in small cell lung cancer. [electronic resource] by
- Lai, C-H
- Park, K-S
- Lee, D-H
- Alberobello, A T
- Raffeld, M
- Pierobon, M
- Pin, E
- Petricoin Iii, E F
- Wang, Y
- Giaccone, G
Producer: 20141126
In:
Oncogene vol. 33
Availability: No items available.
|
|
6.
|
Chemoresistant colorectal cancer cells and cancer stem cells mediate growth and survival of bystander cells. [electronic resource] by
- Bose, D
- Zimmerman, L J
- Pierobon, M
- Petricoin, E
- Tozzi, F
- Parikh, A
- Fan, F
- Dallas, N
- Xia, L
- Gaur, P
- Samuel, S
- Liebler, D C
- Ellis, L M
Producer: 20120319
In:
British journal of cancer vol. 105
Availability: No items available.
|